annual CFI:
-$12.25M+$18.22M(+59.81%)Summary
- As of today (June 29, 2025), IBRX annual cash flow from investing activities is -$12.25 million, with the most recent change of +$18.22 million (+59.81%) on December 31, 2024.
- During the last 3 years, IBRX annual CFI has risen by +$72.64 million (+85.57%).
- IBRX annual CFI is now -144.86% below its all-time high of $27.30 million, reached on December 31, 2022.
Performance
IBRX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$4.13M-$5.71M(-58.01%)Summary
- As of today (June 29, 2025), IBRX quarterly cash flow from investing activities is $4.13 million, with the most recent change of -$5.71 million (-58.01%) on March 31, 2025.
- Over the past year, IBRX quarterly CFI has increased by +$39.75 million (+111.59%).
- IBRX quarterly CFI is now -96.46% below its all-time high of $116.67 million, reached on June 30, 2022.
Performance
IBRX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$27.50M+$39.75M(+324.60%)Summary
- As of today (June 29, 2025), IBRX TTM cash flow from investing activities is $27.50 million, with the most recent change of +$39.75 million (+324.60%) on March 31, 2025.
- Over the past year, IBRX TTM CFI has increased by +$85.11 million (+147.75%).
- IBRX TTM CFI is now -68.79% below its all-time high of $88.13 million, reached on March 31, 2023.
Performance
IBRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
IBRX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +59.8% | +111.6% | +147.8% |
| 3 y3 years | +85.6% | +106.0% | +114.8% |
| 5 y5 years | -166.0% | -70.5% | +96.5% |
IBRX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -144.9% | +85.6% | -96.5% | +106.0% | -68.8% | +114.8% |
| 5 y | 5-year | -144.9% | +85.6% | -96.5% | +103.0% | -68.8% | +114.8% |
| alltime | all time | -144.9% | +85.6% | -96.5% | +103.0% | -68.8% | +114.8% |
IBRX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $4.13M(-58.0%) | $27.50M(-324.6%) |
| Dec 2024 | -$12.25M(-59.8%) | $9.83M(-84.9%) | -$12.25M(-38.2%) |
| Sep 2024 | - | $65.03M(-226.3%) | -$19.83M(-80.3%) |
| Jun 2024 | - | -$51.49M(+44.5%) | -$100.49M(+74.4%) |
| Mar 2024 | - | -$35.62M(-1683.9%) | -$57.61M(+89.1%) |
| Dec 2023 | -$30.47M(-211.6%) | $2.25M(-114.4%) | -$30.47M(-41.0%) |
| Sep 2023 | - | -$15.63M(+81.7%) | -$51.61M(+38.9%) |
| Jun 2023 | - | -$8.60M(+1.4%) | -$37.15M(-142.2%) |
| Mar 2023 | - | -$8.48M(-55.1%) | $88.13M(+222.8%) |
| Dec 2022 | $27.30M | -$18.89M(+1517.6%) | $27.30M(-129.8%) |
| Sep 2022 | - | -$1.17M(-101.0%) | -$91.61M(+14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $116.67M(-268.3%) | -$79.86M(-57.1%) |
| Mar 2022 | - | -$69.31M(-49.7%) | -$186.04M(+119.2%) |
| Dec 2021 | -$84.89M(+328.5%) | -$137.80M(-1402.2%) | -$84.89M(-240.4%) |
| Sep 2021 | - | $10.58M(+0.9%) | $60.46M(-996.2%) |
| Jun 2021 | - | $10.49M(-67.1%) | -$6.75M(+244.0%) |
| Mar 2021 | - | $31.84M(+322.1%) | -$1.96M(-90.1%) |
| Dec 2020 | -$19.81M(-206.8%) | $7.54M(-113.3%) | -$19.81M(-27.6%) |
| Sep 2020 | - | -$56.63M(-470.7%) | -$27.36M(-193.5%) |
| Jun 2020 | - | $15.27M(+9.1%) | $29.27M(+109.1%) |
| Mar 2020 | - | $13.99M | $13.99M |
| Dec 2019 | $18.55M | - | - |
FAQ
- What is ImmunityBio annual cash flow from investing activities?
- What is the all time high annual CFI for ImmunityBio?
- What is ImmunityBio annual CFI year-on-year change?
- What is ImmunityBio quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ImmunityBio?
- What is ImmunityBio quarterly CFI year-on-year change?
- What is ImmunityBio TTM cash flow from investing activities?
- What is the all time high TTM CFI for ImmunityBio?
- What is ImmunityBio TTM CFI year-on-year change?
What is ImmunityBio annual cash flow from investing activities?
The current annual CFI of IBRX is -$12.25M
What is the all time high annual CFI for ImmunityBio?
ImmunityBio all-time high annual cash flow from investing activities is $27.30M
What is ImmunityBio annual CFI year-on-year change?
Over the past year, IBRX annual cash flow from investing activities has changed by +$18.22M (+59.81%)
What is ImmunityBio quarterly cash flow from investing activities?
The current quarterly CFI of IBRX is $4.13M
What is the all time high quarterly CFI for ImmunityBio?
ImmunityBio all-time high quarterly cash flow from investing activities is $116.67M
What is ImmunityBio quarterly CFI year-on-year change?
Over the past year, IBRX quarterly cash flow from investing activities has changed by +$39.75M (+111.59%)
What is ImmunityBio TTM cash flow from investing activities?
The current TTM CFI of IBRX is $27.50M
What is the all time high TTM CFI for ImmunityBio?
ImmunityBio all-time high TTM cash flow from investing activities is $88.13M
What is ImmunityBio TTM CFI year-on-year change?
Over the past year, IBRX TTM cash flow from investing activities has changed by +$85.11M (+147.75%)